Supplementation with HCD is an efficient way to cause dyslipidemia [39]; likewise, STZ-induced type 2 diabetes, achieved through the reduction of insulin secretion from the pancreatic β-cells and its impact on insulin resistance [40], leads to hyperglycemia and associated disorders in a variety of model organisms [41,42], including the zebrafish [43]. This evidence concerns the gene INS and metabolic syndrome.